Skip to main content
SpringerLink
Log in

Phase-II-Studie

Weniger Exazerbationen mit DPP-1-Hemmer bei Bronchiektasien

  • Journalclub
  • Published:
Pneumo News Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Literatur:

  1. Polverino E, Goeminne PC, Mc Donnell MJ et al. European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J. 2017;50(3):1700629

Download references

Author information

Authors and Affiliations

  1. Salzkammergutklinikum Gmunden, Miller-von-Aichholz-Str. 49, 4810, Gmunden, Österreich

    Peter Dovjak

  2. Universität Witten\/Herdecke, Dr.-Moeller-Straße 15, 58332, Schwelm, Germany

    Hans Jürgen Heppner (Chefarzt)

Authors
  1. Peter Dovjak
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hans Jürgen Heppner
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Peter Dovjak.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dovjak, P., Heppner, H. Weniger Exazerbationen mit DPP-1-Hemmer bei Bronchiektasien. Pneumo News 13, 18–19 (2021). https://doi.org/10.1007/s15033-021-2686-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15033-021-2686-z

Search

Navigation